SPRYD7 and prostate neoplasm: ARLTS1 and MLNR had a correlation value of −0.35 (p-value 0.04) in PCa cell lines, and ARLTS1 and SPRYD7 had a correlation value of −0.34 (p-value 0.003) in prostate tumour specimens (Table 3).